The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Triapin 5 mg/5 mg, prolonged release tablets

5/5 milligram(s) Prolonged-release tablet

Primecrown 2010 LimitedPPA1633/042/001

Main Information

Trade NameTriapin 5 mg/5 mg, prolonged release tablets
Active SubstancesFelodipine
Ramipril
Strength5/5 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderPrimecrown 2010 Limited
Licence NumberPPA1633/042/001

Group Information

ATC CodeC09BB ACE inhibitors and calcium channel blockers
C09BB05 ramipril and felodipine

Status

Authorised/WithdrawnAuthorised
Licence Issued11/03/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0032-012-024
Interchangeable List DocumentPDF of Interchangeable List
« Back